title: Determinants of neurosurgical outcome in pituitary tumors.
abstract: OBJECTIVE
  Neurosurgery is one of the main therapies for pituitary tumors; optimising outcome is highly desirable for the patient and the health system. We have analysed predictors of outcome in surgically treated pituitary adenomas operated in this centre.
  
  
  METHODS
  A total of 289 patients underwent neurosurgery for a pituitary tumor, by the same two neurosurgeons, between 1982 and 2001. Their records were examined to find predictors of post-surgical outcome. Thirty-eight percent were males, with a median age of 40.8 (8-82.7) yr; 51.9% had been operated since 1992, 92.2% by the transsphenoidal route. Most tumors (70.2%) were macroadenomas; 28.4% were non-functioning, 27.3% secreted PRL, 26.3% GH of which 14 (4.8%) also secreted PRL, 17.3% ACTH, 0.3% FSH and 0.3% TSH.
  
  
  RESULTS
  A stepwise, forward logistic regression analysis revealed tumor size as the only significant predictor of radiological cure [odds ratio (OR) for macroadenoma 0.16 vs microadenoma, p=0.0005]. Hormonally, PRL-secretion by the tumor was a predictor of poor prognosis (OR 3.29 for cure of non-PRL-secreting tumors, p=0.005), as was tumor size (OR 0.45 for cure of macroadenomas, p=0.005). Considering simultaneous radiological and hormonal remission, tumor size (OR 0.35 for macroadenoma, p=0.0002), and operation date (OR 0.40 for up to 1991, p=0.0002) were the only significant predictors.
  
  
  CONCLUSIONS
  PRL secretion, tumor size and operation date are the main predictors of neurosurgical outcome in pituitary tumors, the latter suggesting that neurosurgical experience plays an important role.
authors.affiliation: Department of Endocrinology, Hospital Sant Pau, Autonomous University of Barcelona, Spain.
authors.forename: M J
authors.initials: MJ
authors.lastname: Barahona
authors.forename: L
authors.initials: L
authors.lastname: Sojo
authors.forename: A M
authors.initials: AM
authors.lastname: Wägner
authors.forename: F
authors.initials: F
authors.lastname: Bartumeus
authors.forename: B
authors.initials: B
authors.lastname: Oliver
authors.forename: P
authors.initials: P
authors.lastname: Cano
authors.forename: S M
authors.initials: SM
authors.lastname: Webb
mesh_terms: D000236:Adenoma / Q000000981:diagnostic imaging / Q000378:metabolism / Q000401:mortality / Q000601:surgery*; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D005260:Female; D019382:Human Growth Hormone / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D019635:Neurosurgical Procedures / Q000379:methods*; D010911:Pituitary Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism / Q000401:mortality / Q000601:surgery*; D011859:Radiography; D012044:Regression Analysis; D016896:Treatment Outcome
chemical_list: D019382:Human Growth Hormone; D000324:Adrenocorticotropic Hormone